Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group (Q73676552)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 April 2000
edit
Language Label Description Also known as
English
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group
scientific article published on 01 April 2000

    Statements

    title
    Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    10765119
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10765119%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    5 November 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q73676552&oldid=1745711247"